Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma

Recently many studies have demonstrated that the degree of tumor angiogenesis is related to the aggressiveness of the tumor and clinical outcome. Vascular endothelial growth factor (VEGF) is a well characterized inducer of angiogenesis. In this study, the authors investigated the prognostic significance of VEGF expression in patients with early gastric carcinoma together with p53 gene abnormality and tumor cell proliferation.

[1]  Y. Kakeji,et al.  Long term survival of patients with stage IV gastric carcinoma , 1998, Cancer.

[2]  T. Sawada,et al.  Overexpression of p53 associated with tumor angiogenesis, tumor cell proliferation, and prognosis in gastric carcinoma. , 1997, Oncology reports.

[3]  Y. Chung,et al.  Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma. , 1997, British Journal of Cancer.

[4]  J. Folkman,et al.  Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.

[5]  H. Juhl,et al.  Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans , 1996, Nature Medicine.

[6]  T. Sawada,et al.  Prognostic value of vascular endothelial growth factor expression in gastric carcinoma , 1996, Cancer.

[7]  L. Ellis,et al.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. , 1995, Cancer research.

[8]  Y. Chung,et al.  Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. , 1995, British Journal of Cancer.

[9]  Y. Chung,et al.  Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Toi,et al.  Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer , 1994, Japanese journal of cancer research : Gann.

[11]  K. Sawai,et al.  New trends in surgery for gastric cancer in Japan , 1994, Journal of surgical oncology.

[12]  M. Inoue,et al.  Clinicopathological characteristics of p53 overexpression in endometrial cancers , 1994, International journal of cancer.

[13]  A. Arakawa,et al.  Recurrent death among early gastric cancer patients: 20-years' experience. , 1994, Hepato-gastroenterology.

[14]  M. Yamaoka,et al.  Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). , 1993, Cancer research.

[15]  Kazutomo Inoue,et al.  Comparison of Survival Curves of Gastric Cancer Patients After Surgery According to the UICC Stage Classification and the General Rules for Gastric Cancer Study by the Japanese Research Society for Gastric Cancer , 1993, Annals of surgery.

[16]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[17]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[18]  D. Lane,et al.  p53 expression and prognosis in gastric carcinoma , 1992, International journal of cancer.

[19]  T. Muto,et al.  Lymph node metastasis from early gastric cancer: endoscopic resection of tumour , 1992, The British journal of surgery.

[20]  Harold E. Dvorak,et al.  Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels , 1991, The Journal of experimental medicine.

[21]  K. Sugimachi,et al.  Recurrence in early gastric cancer. , 1990, Surgery.

[22]  J. Folkman What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[23]  K. Okita,et al.  Significance of Strip Biopsy, with Particular Reference to Endoscopic “Mucosectomy” , 1989 .

[24]  E. Tan,et al.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. , 1987, Archives of pathology & laboratory medicine.

[25]  D.,et al.  Regression Models and Life-Tables , 2022 .